MARKET

VIVO

VIVO

Meridian Biosci
NASDAQ

Real-time Quotes | Nasdaq Last Sale

25.46
-0.53
-2.04%
Closed 18:47 08/04 EDT
OPEN
25.83
PREV CLOSE
25.99
HIGH
25.83
LOW
24.68
VOLUME
610.38K
TURNOVER
--
52 WEEK HIGH
26.14
52 WEEK LOW
5.51
MARKET CAP
1.09B
P/E (TTM)
51.16
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 1 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average VIVO stock price target is 9.00 with a high estimate of 9.00 and a low estimate of 9.00.

EPS

VIVO News

More
Meridian Bioscience (VIVO) Stock Sinks As Market Gains: What You Should Know
Meridian Bioscience (VIVO) closed at $24.49 in the latest trading session, marking a -1.84% move from the prior day.
Zacks · 4d ago
Meridian Bioscience (VIVO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Meridian Bioscience (VIVO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks · 4d ago
Meridian Core Business Facing Difficulties Beyond COVID-19 Bonanza
Seeking Alpha · 6d ago
Did Hedge Funds Make The Right Call On Meridian Bioscience, Inc. (VIVO) ?
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors. With billions of dollars in assets, professional invest
Insider Monkey · 07/28 14:24
Meridian Bioscience Announces New Board Member - Anthony Bihl
CINCINNATI, July 28, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) announces the appointment of Anthony Bihl III to its Board of Directors, effective immediately. “We welcome Tony to the board as a new independent director and look forward
GlobeNewswire · 07/28 13:00
Biotech Bonanza - Second Half Outlook
Seeking Alpha · 07/28 12:24
Benzinga's Top Upgrades, Downgrades For July 27, 2020
Upgrades * For First Community Corp (NASDAQ: FCCO), Raymond James upgraded the previous rating of Market Perform to the current rating Outperform. In the second quarter, First Community showed an EPS of $0.30, compared to $0.37 from the year-ago quarter. At
Benzinga · 07/27 13:33
The Daily Biotech Pulse: Opko Wins CDC Contract, Novartis Lowers Guidance, Pieris Study Placed On Partial Clinical Hold
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 20)
Benzinga · 07/21 11:59

Industry

Medical Equipment, Supplies & Distribution
-0.51%
Healthcare Equipment & Supplies
-0.51%

Hot Stocks

Symbol
Price
%Change

About VIVO

Meridian Bioscience, Inc. is a life science company engaged in the development, manufacture, sale and distribution of diagnostic test kits for gastrointestinal, viral, respiratory and parasitic infectious diseases, and elevated blood lead levels, and the manufacture and distribution of bulk antigens, antibodies, polymerase chain reaction (PCR)/quantitative PCR (qPCR) reagents, nucleotides, competent cells and bioresearch reagents used by researchers and other diagnostic manufacturers. Its segments include Diagnostics and Life Science. The Diagnostics segment includes manufacturing operations in Cincinnati, and the sale and distribution of diagnostic test kits in the countries consisting of North, Central and South America; Europe, the Middle East and Africa (EMEA), and other countries outside of the Americas and EMEA. The Life Science segment consists of manufacturing operations in Memphis, Tennessee; Boca Raton, Florida; London, England; Luckenwalde, Germany, and Sydney, Australia.
More

Webull offers kinds of Meridian Bioscience, Inc. stock information, including NASDAQ:VIVO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VIVO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading VIVO stock methods without spending real money on the virtual paper trading platform.